Government to use Vaccine Taskforce model to tackle health challenges
Patients will benefit from cutting-edge new treatments as the government introduces a Vaccine Taskforce style approach to tackling health challenges.
Source: gov.uk
📰 Project Orbis News
Page 6 - Project Orbis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Project Orbis. Real-time updates on events, politics, business and more.
NHS England to fast-track prostate drug which can prolong survival by years
It will be the first health service in Europe to offer it after a post-Brexit partnership between UK, US and Australian medicines regulators
United Kingdom Amanda Pritchard Peter Johnson Antonio Payano National Institute Of Clinical Excellence Regulatory Agency
Source: telegraph.co.uk
NICE recommends new treatment for EGFR-positive lung cancer
New therapy Mobocertinib, recommended by NICE, helps slow growth of EGFR-positive non small cell lung cancer in chemo-treated patients.
Mobocertinib Exkivity Helen Knight National Institute For Health National Institute Care Excellence Project Orbis
Source: europeanpharmaceuticalreview.com
Cancer drug cooperation could save 1.5 mn lives a year: researchers
PARIS, France - Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday. The figure was based on how long it took two recent cancer drugs to be approved across the world after they were given the green light
Source: mb.com.ph
Cancer drug cooperation could save 1.5m lives a year: researchers
Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday.The figure was based on how long it took two recent...
Source: thenews.com.pk
Report says 20% of global cancer deaths could be avoided
A new study by the Bloomberg New Economy International Cancer Coalition says at least 20% of global cancer deaths could be avoided each year.
Michaelr Bloomberg Mary Gospodarowicz Kevin Rudd Bloomberg New Economy Forum Drug Administration Bloomberg New Economy International Cancer Coalition
Source: labiotech.eu
Lack of global regulatory coordination for cancer clinical trials costs 1.5 million lives a year despite therapies being available
/PRNewswire/ -- A new study by members of the Bloomberg New Economy International Cancer Coalition (the Coalition) says that at least 1.5 million deaths...
United States Michaelr Bloomberg Mary Gospodarowicz Kevin Rudd Bloomberg New Economy Forum Drug Administration
Source: prnewswire.com
Cancer treatment: Are we stalling the cure?
Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs.
Source: thesouthafrican.com
FDA Approves Durvalumab Plus Chemo for Biliary Tract Cancer
The immune checkpoint inhibitor is already approved for use in lung cancer. Now it is also approved for use in combination with chemotherapy for locally advanced or metastatic biliary tract cancer.
Soult Ukpyolsi South Korea United States Cathy Eng Australian Therapeutic Goods Administration Singapore Health Sciences Authority
Source: medscape.com
IMFINZI® (durvalumab) Plus Chemotherapy Approved in the US as the First Immunotherapy Regimen for Pa
Approval based on TOPAZ-1 Phase III trial results, which showed IMFINZI combination reduced risk of death by 20% vs. chemotherapy aloneWILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tra...
United States United Kingdom Medstar Georgetown University Hospital District Of Columbia South Korea Dave Fredrickson
Source: pharmiweb.com